All Stories

  1. Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib

    Article • OncoTargets and Therapy, November 2018, Dove Medical Press

    zhu youcai

  2. A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib

    Article • Cancer Biology & Therapy, August 2018, Taylor & Francis

    zhu youcai

  3. Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesions

    Article • Thoracic Cancer, May 2018, Wiley

    zhu youcai

  4. Dual drive coexistence of EML4-ALK and TPM3-ROS1 fusion in advanced lung adenocarcinoma

    Article • Thoracic Cancer, December 2017, Wiley

    zhu youcai

  5. Hemangioma of the rib: a rare case report and literature review

    Article • Open Medicine, August 2017, De Gruyter

    zhu youcai

  6. Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report

    Article • OncoTargets and Therapy, June 2017, Dove Medical Press

    zhu youcai

  7. Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature

    Article • OncoTargets and Therapy, July 2016, Dove Medical Press

    zhu youcai